AGIOS PHARMACEUTICALS, INC. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Agios Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -47.1 %, a 133% decline year-over-year.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2023 was -38.1 %, a 84.1% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2022 was -20.7 %, a 122% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2021 was 95.7 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -38.1 -17.4 -84.1% Jan 1, 2023 Dec 31, 2023
2022 -20.7 -116 -122% Jan 1, 2022 Dec 31, 2022
2021 95.7 +159 Jan 1, 2021 Dec 31, 2021
2020 -63.5 +9.97 +13.6% Jan 1, 2020 Dec 31, 2020
2019 -73.4 -29.3 -66.4% Jan 1, 2019 Dec 31, 2019
2018 -44.1 +32.5 +42.4% Jan 1, 2018 Dec 31, 2018
2017 -76.7 -19.2 -33.4% Jan 1, 2017 Dec 31, 2017
2016 -57.5 -27.1 -89.4% Jan 1, 2016 Dec 31, 2016
2015 -30.4 -7.91 -35.3% Jan 1, 2015 Dec 31, 2015
2014 -22.4 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.